Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
about
Molecular surveillance of the antifolate-resistant mutation I164L in imported African isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEuropDrug-resistant malaria in Sudan: A review of evidence and scenarios for the futureAn optimized microarray platform for assaying genomic variation in Plasmodium falciparum field populationsTrends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-PyrimethaminePolymorphism in drug resistance genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium falciparum in some states of IndiaGold mining areas in Suriname: reservoirs of malaria resistance?Adaptive copy number evolution in malaria parasitesSubmicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western KenyaMultiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malariaEffects of point mutations in Plasmodium falciparum dihydrofolate reductase and dihydropterate synthase genes on clinical outcomes and in vitro susceptibility to sulfadoxine and pyrimethamineFive years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll outFitness trade-offs in the evolution of dihydrofolate reductase and drug resistance in Plasmodium falciparumSurveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countriesA process similar to autophagy is associated with cytocidal chloroquine resistance in Plasmodium falciparumDihydrofolate-Reductase Mutations in Plasmodium knowlesi Appear Unrelated to Selective Drug Pressure from Putative Human-To-Human Transmission in Sabah, MalaysiaTargeting purine and pyrimidine metabolism in human apicomplexan parasitesMolecular surveillance as monitoring tool for drug-resistant Plasmodium falciparum in Suriname.Biochemical and functional characterization of Plasmodium falciparum GTP cyclohydrolase IWorld Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.Origin of robustness in generating drug-resistant malaria parasitesMutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia.Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.Genetic variability of Plasmodium malariae dihydropteroate synthase (dhps) in four Asian countries.Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi.Monitoring Plasmodium falciparum growth and development by UV flow cytometry using an optimized Hoechst-thiazole orange staining strategy.Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivaxRandomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations.Transmission and cross-mating of high-level resistance Plasmodium falciparum dihydrofolate reductase haplotypes in The GambiaMarkers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolatesMolecular surveillance of Plasmodium vivax dhfr and dhps mutations in isolates from Afghanistan.Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.A molecular surveillance system for global patterns of drug resistance in imported malariaAllelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malariaIntermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99.Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, MalawiAssociation between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children.Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia.Independent origin of plasmodium falciparum antifolate super-resistance, Uganda, Tanzania, and Ethiopia.
P2860
Q24807035-3B9EBE1A-C5A9-402B-991D-CC11A3C42B2AQ26860010-0E1F1F6F-4343-4258-9E76-1E6C605BC65EQ28031409-7E8B7054-562D-4811-8F2F-37687C219334Q28125907-9EDFB6B6-0669-4372-95D9-720513C37820Q28125923-7BA4DD99-DB3B-4B4B-A74B-86D7C90364ADQ28125924-79AA6D2C-D9E6-4501-BBE2-5AD326954884Q28125941-780BC018-F23E-4EF6-89B8-0A61A71AAE5EQ28473933-37C958E0-585D-4A46-B076-5C20C6361F9BQ28474692-AFB03115-F84A-4F77-94EC-56F621F9080EQ28475195-93960437-63A8-4A17-B2CB-E4F57D410003Q28476005-4E5FA984-D8AE-4A2F-A000-6366B1B3C4FFQ28477515-D08A8F66-3250-4036-B390-BF0316301B6EQ28478215-9F2066C1-7A4F-480B-826D-66054671C571Q28534753-18A44E39-6390-4105-BE76-E70C5829EF37Q28535307-1480888C-A096-471F-9488-29073355D59AQ28550436-3E097CA9-7FFC-4D44-A284-FC3AD7B8F0D7Q28629739-ED0CFAEE-FDA8-48DE-A678-41F1DA09620EQ29353745-EE8DF403-80E9-4684-9A56-42F6780D0843Q30044485-55BDBA75-EDAD-452F-A0B2-0BCF3B3CF1E4Q30483555-D131FFE4-FA16-4637-A0CC-8892C8186465Q30581496-F76F4019-F629-414A-97E3-F367B053F3D6Q30984906-8BC7DE45-9E8E-424A-A600-961C0C3A2C98Q31118886-974E2980-358D-480B-B448-8BE83C2E46B8Q31156173-A7EE5D4A-56E0-4141-BF94-4B21378EB218Q33319559-23978944-ABE3-40FF-80DD-57416DB94CE8Q33321282-3A2AAA8D-FAD1-426E-AADB-4F1AA65BECB9Q33371043-7049DA0E-F383-4B71-9120-405B797126AAQ33507089-3F14D366-B631-4F63-9A28-97AFBD5BC7FAQ33723453-4BB5ED5C-CD1E-4C90-B9BC-B74BD9560954Q33749694-ECADE289-D870-4A64-9C05-B75E9E970938Q33752129-0779A7EE-68E8-4BE2-813D-1EEF06182DE1Q33766158-13D4E4C7-2EA8-4A33-BBF0-EA2AC23FB51BQ33817503-99EF05FE-34E2-4C01-9DEE-0353DA119720Q33865549-634A4ED5-7E7E-4570-A91F-F9FD48A542F2Q33889085-04E62DF7-36A2-4303-84AB-F6B6700B7AE6Q33929315-0CD29DDE-2C77-4C21-ADDC-E6AD38D1F4F6Q33935361-1C8AC56C-B599-4898-8291-3AFA77622703Q33935430-2645D64A-C14E-4007-8C06-E09791ECC3E9Q33938016-94F06F37-F778-4B6A-9AAE-5D7A529C9F11Q33950981-9DF40CD2-A166-4578-B868-62B78F222873
P2860
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Mutations in Plasmodium falcip ...... ulfadoxine use and resistance.
@en
Mutations in Plasmodium falcip ...... ulfadoxine use and resistance.
@nl
type
label
Mutations in Plasmodium falcip ...... ulfadoxine use and resistance.
@en
Mutations in Plasmodium falcip ...... ulfadoxine use and resistance.
@nl
prefLabel
Mutations in Plasmodium falcip ...... ulfadoxine use and resistance.
@en
Mutations in Plasmodium falcip ...... ulfadoxine use and resistance.
@nl
P2093
P356
P1476
Mutations in Plasmodium falcip ...... ulfadoxine use and resistance.
@en
P2093
Cespedes JL
Cortese JF
Estrada-Franco JG
Mollinedo RE
Nwanyanwu OC
Watkins WM
Winstanley PA
P304
P356
10.1086/514159
P407
P577
1997-12-01T00:00:00Z